Terms: = Ovarian cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
102 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. runx1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.
Yu X; Zhao P; Luo Q; Wu X; Wang Y; Nan Y; Liu S; Gao W; Li B; Liu Z; Cui Z
Oncogene; 2024 Feb; 43(6):420-433. PubMed ID: 38092960
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-related acute myeloid leukemia with
Yang X; Liu Q; Zhang R; Yang X; Wang L; Zhang Z; Li Y; Lin L
Indian J Pathol Microbiol; 2023; 66(4):865-867. PubMed ID: 38084551
[TBL] [Abstract] [Full Text] [Related]
4. runx1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma.
Zhang Y; Sun S; Qi Y; Dai Y; Hao Y; Xin M; Xu R; Chen H; Wu X; Liu Q; Kong C; Zhang G; Wang P; Guo Q
J Ovarian Res; 2023 Oct; 16(1):200. PubMed ID: 37817210
[TBL] [Abstract] [Full Text] [Related]
6. Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.
Fan B; Schooling CM; Zhao JV
J Hum Hypertens; 2023 Nov; 37(11):1028-1032. PubMed ID: 37117874
[TBL] [Abstract] [Full Text] [Related]
7. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial.
Waterhouse M; Ebeling PR; McLeod DSA; English D; Romero BD; Baxter C; Armstrong BK; Hartel G; Kimlin M; O'Connell RL; van der Pols JC; Venn AJ; Webb PM; Whiteman DC; Neale RE
Lancet Diabetes Endocrinol; 2023 May; 11(5):324-332. PubMed ID: 37011645
[TBL] [Abstract] [Full Text] [Related]
8. Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression.
Pierson Smela MD; Kramme CC; Fortuna PRJ; Adams JL; Su R; Dong E; Kobayashi M; Brixi G; Kavirayuni VS; Tysinger E; Kohman RE; Shioda T; Chatterjee P; Church GM
Elife; 2023 Feb; 12():. PubMed ID: 36803359
[TBL] [Abstract] [Full Text] [Related]
9. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer.
Wu Y; Jiang W; Fu L; Ren M; Ai H; Wang X
Abdom Radiol (NY); 2023 Feb; 48(2):733-743. PubMed ID: 36445408
[TBL] [Abstract] [Full Text] [Related]
10. Loss of
Bridges K; Yao HH; Nicol B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430923
[TBL] [Abstract] [Full Text] [Related]
11. Dietary Vitamin A Intake and Circulating Vitamin A Concentrations and the Risk of Three Common cancers in Women: A Meta-Analysis.
Han X; Zhao R; Wang Y; Ma H; Yu M; Chen X; Zhang D; Ma S; Liu B; Cai H
Oxid Med Cell Longev; 2022; 2022():7686405. PubMed ID: 36388168
[TBL] [Abstract] [Full Text] [Related]
12. PROM1, CXCL8, runx1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
Dansonka-Mieszkowska A; Szafron LA; Kulesza M; Stachurska A; Leszczynski P; Tomczyk-Szatkowska A; Sobiczewski P; Parada J; Kulinczak M; Moes-Sosnowska J; Pienkowska-Grela B; Kupryjanczyk J; Chechlinska M; Szafron LM
PLoS One; 2022; 17(7):e0271539. PubMed ID: 35867729
[TBL] [Abstract] [Full Text] [Related]
13. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract] [Full Text] [Related]
14. Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in ovarian cancer: A Randomized Clinical Trial.
Lim MC; Chang SJ; Park B; Yoo HJ; Yoo CW; Nam BH; Park SY;
JAMA Surg; 2022 May; 157(5):374-383. PubMed ID: 35262624
[TBL] [Abstract] [Full Text] [Related]
15. Association of Spironolactone Use With Risk of cancer: A Systematic Review and Meta-analysis.
Bommareddy K; Hamade H; Lopez-Olivo MA; Wehner M; Tosh T; Barbieri JS
JAMA Dermatol; 2022 Mar; 158(3):275-282. PubMed ID: 35138351
[TBL] [Abstract] [Full Text] [Related]
16. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet Oncol; 2022 Mar; 23(3):382-392. PubMed ID: 35123662
[TBL] [Abstract] [Full Text] [Related]
17. ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study.
Machtinger R; Fallach N; Goldstein I; Chodick G; Schiff E; Orvieto R; Mashiach R
Hum Reprod; 2022 Mar; 37(3):577-585. PubMed ID: 34871410
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
AlMahdy AM; Elassall GM; Abdelbadee AY; Abd-Elkariem AY; Atef F; Ahmed IA; Sayed EG; Salah MA; Ali AK; Ragab EY; Abd Elazeem HAS; Saad MM; Shazly SA;
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():179-185. PubMed ID: 34814044
[TBL] [Abstract] [Full Text] [Related]
19. Survival and Surgical Approach among Women with Advanced ovarian cancer Treated with Neoadjuvant Chemotherapy.
Persenaire C; Pyrzak A; Barber EL
J Minim Invasive Gynecol; 2022 Mar; 29(3):375-384. PubMed ID: 34648931
[TBL] [Abstract] [Full Text] [Related]
20. Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis.
Hosseininasab-Nodoushan SA; Ghazvini K; Jamialahmadi T; Keikha M; Sahebkar A
Semin Cancer Biol; 2022 Nov; 86(Pt 2):923-928. PubMed ID: 34333041
[TBL] [Abstract] [Full Text] [Related]
[Next]
